General Announcement::ASX:TLX; Nasdaq:TLX - ProstACT Global Study Status

Issuer & Securities

Issuer/ Manager
TELIX PHARMACEUTICALS LIMITED
Securities
TELIXPHAR A$650M2.375%N290730 - XS2862961492 - JWQB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
17-Dec-2025 16:20:59
Status
New
Announcement Sub Title
ASX:TLX; Nasdaq:TLX - ProstACT Global Study Status
Announcement Reference
SG251217OTHRVE8F
Submitted By (Co./ Ind. Name)
Marbill De Gracia
Designation
Secretariat
Effective Date and Time of the event
17/12/2025 19:18:00
Description (Please provide a detailed description of the event in the box below)
ASX:TLX; Nasdaq:TLX - ProstACT Global Study Status

Attachments

20251217 ProstACT Global Update vFINAL.pdf
Total size =214K